May 28, 2012 Issue | Chemical & Engineering News
 
 

What Is Tinsel Made Of? Speaking of Chemistry Ep. 12

How is the shiny tinsel that decorates many Christmas trees made? Find out all about tinsel's chemistry history in this very special holiday episode of Speaking of Chemistry.

 
Copyright © 2012 American Chemical Society
 

May 28, 2012 Issue

Volume 90, Issue 22
09022-cover1-MAON401cxd
May 28, 2012 Issue, Vol. 90 | Iss. 22
As pharmaceutical manufacturers increasingly use enzymatic reactions in their processes, a robust business model still eludes biocatalysis companies
By Ann M. Thayer
(pp. 13-18)
Features
Government & Policy
Chemical firms take their beef over rates and service to a transportation board (pp. 37-40)
Science & Technology
Concerns grow over nanoparticle characterization and purity (pp. 48-50)
Back Issues
 

Cover Story: Biocatalysis

Pharma Strives For Green Goals
Technology and metrics are major factors in drug firms’ approaches to reducing waste
(pp. 20-24)
 

News of the Week

Leaders Set Mix Of Goals

International: G-8 Summit discussions include energy, climate, and agriculture
(p.7)

A Step Forward For Quantum Dots

Nanomedicine: Researchers see no negative health effects of the tiny particles in monkeys
(p.8)

DSM Will Acquire Ocean Nutrition

Supplements: Purchase advances chemical company’s position in omega-3 fatty acids
(p.8)

Cracker Builders Unite

France's Technip is acquiring Stone & Webster from Shaw Group
(p.9)

Nanocrystal Growth Observed

Imaging: Using electron microscopy, researchers reveal mechanism of nanoparticle fusion
(p.9)

Jaczko Heads For The Exit

Government: Embattled NRC chairman says he is stepping down
(p.10)

Single Molecule Channels Water

Nanotechnology: Molecular tube transports water across lipid membrane
(p.10)

Changing Science Teaching

Education: Students learn better from interactive methods, report says
(p.11)

Surface Do-Overs

Photochemistry: Rapid reaction attaches protein or dyes
(p.11)
 

Departments

09022-bus2-RPLabbayscxd

Business

Exit of a major supplier has lab chemical makers scrambling
(pp. 30-32)
Claims and counterclaims obscure truth in case pitting U.S. resin maker against Chinese rival
(pp. 28-29)
Clinical experience will bring focus to the data surge of genomics
(p.34)
As pharmaceutical manufacturers increasingly use enzymatic reactions in their processes, a robust business model still eludes biocatalysis companies
(pp. 13-18)
Technology and metrics are major factors in drug firms’ approaches to reducing waste
(pp. 20-24)

ACS News

ACS members take on Capitol Hill to lobby for more federal support for research
(p.55)

Government & Policy

NIH initiative aims to partner academics with pharmaceutical companies to revive failed drug candidates
(pp. 41-43)
Chemical firms take their beef over rates and service to a transportation board
(pp. 37-40)
EPA wants some information submitted for REACH, but companies say they can’t share the information
(pp. 44-45)

Education

Proposed framework for K–12 education aims for depth over breadth
(p.54)